147 related articles for article (PubMed ID: 6251327)
1. Neurotransmitter receptors-biochemistry and alterations in nueropsychiatric disorders.
Olsen RW; Reisine TD; Yamamura HI
Life Sci; 1980 Sep; 27(10):801-8. PubMed ID: 6251327
[No Abstract] [Full Text] [Related]
2. Central nervous system receptors in neuropsychiatric disorders.
Kato G; Ban T
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):207-22. PubMed ID: 6216501
[TBL] [Abstract][Full Text] [Related]
3. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
[No Abstract] [Full Text] [Related]
4. Neurotransmitter, opiate and benzodiazepine receptor binding of tetrahydroisoquinolines and beta-carbolines in brain membranes.
Nimit Y; Schulze I; Cashaw JL; Ruchirawat S; Davis VE
Prog Clin Biol Res; 1982; 90():311-20. PubMed ID: 6287493
[No Abstract] [Full Text] [Related]
5. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
Friedhoff AJ; Alpert M
Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
[No Abstract] [Full Text] [Related]
6. Brain catecholamines and neurological disease.
Wurtman RJ; Moskowitz MA
Trans Am Neurol Assoc; 1974; 99():149-59. PubMed ID: 4282535
[No Abstract] [Full Text] [Related]
7. Dopamine receptors in the brain.
Iversen LL
Science; 1975 Jun; 188(4193):1084-9. PubMed ID: 2976
[No Abstract] [Full Text] [Related]
8. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans.
Hartline KM; Owens MJ; Nemeroff CB
Ann N Y Acad Sci; 1996 Mar; 780():96-105. PubMed ID: 8602742
[No Abstract] [Full Text] [Related]
9. GABA and neuropsychiatric disorders.
Enna SJ
Can J Neurol Sci; 1980 Aug; 7(3):257-9. PubMed ID: 6449991
[No Abstract] [Full Text] [Related]
10. Sodium-independent, high-affinity binding of [3H]gamma-aminobutyric acid in human neurological disorders.
Lloyd KG; Dreksler S; Shemen L; Davidson L
Adv Exp Med Biol; 1979; 123():399-418. PubMed ID: 160192
[TBL] [Abstract][Full Text] [Related]
11. Drug receptors--an overview.
Vaidya AB
J Assoc Physicians India; 1978 Aug; 26(8):727-34. PubMed ID: 215590
[No Abstract] [Full Text] [Related]
12. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Davis KL; Berger PA
Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524
[TBL] [Abstract][Full Text] [Related]
13. [A review on neurotransmitter in clinical neurology (author's transl)].
Kanazawa I
No To Shinkei; 1977 Dec; 29(12):1245-60. PubMed ID: 74257
[No Abstract] [Full Text] [Related]
14. Amine precursors in neurologic disorders and the psychoses.
Klawans H
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():259-76. PubMed ID: 130667
[No Abstract] [Full Text] [Related]
15. The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders.
Stahl SM
Arch Gen Psychiatry; 1977 May; 34(5):509-16. PubMed ID: 140632
[TBL] [Abstract][Full Text] [Related]
16. Transmitter receptor alterations in Parkinson's disease.
Calne DB; Stoessl AJ
Adv Neurol; 1987; 45():45-9. PubMed ID: 2881449
[No Abstract] [Full Text] [Related]
17. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies.
Nemeroff CB; Bissette G
Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745
[TBL] [Abstract][Full Text] [Related]
18. Imidazoline binding sites in Huntington's and Parkinson's disease putamen.
Reynolds GP; Boulton RM; Pearson SJ; Hudson AL; Nutt DJ
Eur J Pharmacol; 1996 Apr; 301(1-3):R19-21. PubMed ID: 8773473
[TBL] [Abstract][Full Text] [Related]
19. Opiate and benzodiazepine receptors.
Snyder SH
Psychosomatics; 1981 Nov; 22(11):986-9. PubMed ID: 6273959
[No Abstract] [Full Text] [Related]
20. Neurotransmitter interactions related to central dopamine neurons.
Lloyd KG
Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
